Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Intervention Program topic
No spam. Unsubscribe anytime.
Board hears updates on executive‑office reviews of intervention work‑access and terminations
Summary
Board staff reported that the Executive Officer has re‑reviewed IEC recommendations that asked for participants to return to RN work with medication access; some IEC requests were approved, others were returned for lack of supporting evidence. The EO is also reviewing IEC recommendations for program termination citing "failure to derive benefit."
Board staff told the Enforcement Investigations and Intervention Committee on May 29 that the Executive Officer (EO) is re‑reviewing Intervention Evaluation Committee (IEC) recommendations that require participants to return to clinical RN positions or to work with medication access and is also reviewing IEC‑recommended terminations for “failure to derive benefit.”
What the board heard: Yvonne (Intervention program staff) reported the EO has approved some IEC requests for return‑to‑work with or without narcotics access where supporting evidence existed; other IEC recommendations were returned to committee when staff determined the record did not support the requirement.
Why it matters: Several public commenters and board members flagged concern that IECs were inconsistently imposing requirements that a participant return to patient care and potentially have narcotics access. Board counsel and management stressed that such requirements are case‑by‑case and that the EO’s re‑review process is intended to ensure IEC recommendations have appropriate supporting evidence.
Clarifying details and discussion: - EO reviews: Staff said EO review has resulted in some approvals and some returns to IECs when documentation or safety evidence was not present. The EO is now reviewing recommended terminations for “failure to derive benefit” (a regulatory ground for termination when a participant does not make demonstrable recovery progress). - “Failure to derive benefit” examples from discussion: participants who have not shown measurable recovery progress after extended program participation, participants with continuous sobriety but “no recovery efforts,” or those who decline treatment and do not engage in recommended recovery activities; staff emphasized determinations are fact‑specific and may take many months to resolve when participants are in residential or intensive treatments. - Case management communications: Several public commenters said they had inconsistent messages from case managers at the vendor (Premier Health Group); staff requested that participants who feel misinformed should contact BRN intervention staff via the intervention inbox. - Work with access is not an across‑the‑board requirement: Staff and counsel reiterated that requiring work with narcotics access has not been a universal requirement and is imposed only when supported by the individual’s recovery plan and safety evidence; some IEC recommendations for access were returned on re‑review when evidence was lacking.
Public comment: Multiple intervention participants described difficulty getting stable case‑manager assignments during the vendor transition and asked for clearer, written guidance about how EO re‑reviews would be handled. The board committed to clarifying lines of communication and the paperwork participants should file.
What the board did not decide: No regulatory changes were adopted at the meeting; EO re‑review remains an internal oversight step and program staff said they will continue to report when systemic problems are identified.
